Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Language
Year range
1.
The Korean Journal of Hepatology ; : 513-520, 2007.
Article in Korean | WPRIM | ID: wpr-36324

ABSTRACT

BACKGROUND AND AIMS: Lamivudine is an effective, safe therapeutic agent for the treatment of chronic hepatitis B. The aim of this study was to investigate whether early suppression of the viral load predicts HBeAg loss within 1 year during lamivudine therapy. METHODS: This prospective study encompassed 74 patients (mean age: 37.1 years, male/female: 51/23) who were positive HBeAg, their AST or ALT levels were > or =2 times the upper limit of normal and their HBV DNA was > or =10(5) copies/mL. The patients received lamivudine 100 mg for 12 months with monitoring their HBV DNA, AST, ALT, HBeAg and anti-HBe, and all these tests were performed at pretreatment and 1, 3, 6, 9 and 12 months after treatment. The serum HBV DNA was measured by HBV branched DNA assay. RESULTS: HBeAg loss was observed in 12 patients (16.2%), and 9 patients achieved anti-HBe seroconversion during up to 1 year of lamivudine therapy. The mean time to HBeAg loss was 5.6 months (range: 1-12 months). The posttreatment HBV DNA (<2,000 copies/mL) after 3 month (P=0.008) and 6 month (P=0.012)) were significant predictors of HBeAg loss after 1 year of lamivudine treatment on univariate analysis. Pretreatment HBV DNA, AST/ALT, gender, age and liver cirrhosis had no impact on HBeAg loss. The six-month posttreatment HBV DNA level <2,000 copies/mL was a significant predictor of HBeAg loss on multivariate analysis (P=0.008, odds ratio=0.108). CONCLUSION: We suggest that an HBV DNA level <2,000 copies/mL at 6 month after lamivudine therapy is the most important predictor of HBeAg loss during up to 1 year of lamivudine therapy.


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Alanine Transaminase/blood , Antiviral Agents/administration & dosage , Aspartate Aminotransferases/blood , DNA, Viral/blood , Hepatitis B e Antigens/blood , Hepatitis B virus/genetics , Hepatitis B, Chronic/drug therapy , Lamivudine/administration & dosage , Predictive Value of Tests , Treatment Outcome
2.
Korean Circulation Journal ; : 68-71, 2003.
Article in Korean | WPRIM | ID: wpr-54256

ABSTRACT

Neurofibromatosis type 1 (NF-1), or von Recklinhausen's disease, is an autosomal dominant disorder that primarily affects the skin, the central and peripheral nervous systems, and the skeleton. Vasculopathy, such as, aneurysm or stenosis of large vessels is a less common manifestation of NF-1, but spontaneous aortic dissection in NF-1 is very rare. We report a case of acute aortic dissection with incidental aneurysm of the right femoral artery in NF-1.


Subject(s)
Humans , Aneurysm , Constriction, Pathologic , Femoral Artery , Neurofibromatoses , Neurofibromatosis 1 , Peripheral Nervous System , Skeleton , Skin
3.
Korean Journal of Gastrointestinal Endoscopy ; : 169-172, 2002.
Article in Korean | WPRIM | ID: wpr-17856

ABSTRACT

Colonic polyp is one of the most common lesions during colonoscopy, but appendiceal polyp is very rare. Moreover appendiceal intussusception associated with appendiceal polyp is extremly rare. Most appendiceal polyp is rarely diagnosed preoperatively, and diagnosed by postoperative pathologic specimen. We report a case of a 52-year old woman with appendiceal intussusception induced by appendiceal adenoma. She experienced sustained right lower quadrant pain for one month. Double contrast barium enema showed a mass in the cecal base without normal appendiceal filling and colonoscopy showed intussuscepted appendix with polyp on the tip. Endoscopic polypectomy with endoloop and snare was performed successfully without any complication.


Subject(s)
Female , Humans , Middle Aged , Adenoma , Appendix , Barium , Colonic Polyps , Colonoscopy , Enema , Intussusception , Polyps , SNARE Proteins
4.
Tuberculosis and Respiratory Diseases ; : 411-418, 2002.
Article in Korean | WPRIM | ID: wpr-137759

ABSTRACT

Pulmonary alveolar proteinosis(PAP) is a disorder in which an insoluble, proteinaceous material, rich in phospholipids, is deposited in the alveoli and bronchioles. The deficiency in the clearance and degradation of the i ntra-alveolar phospholipoproteinaceous material in PAP most likely represents a dysfunction of the type II pneumocytes. Although the pathogenesis and causative treatment of PAP is unclear a whole lung bronchopulmonary lavage is a relatively safe and effective treatment. Here we experienced a case of pulmonary alveolar proteinosis in a 62 year old female patient who had pulmonary tuberculosis approximately 20 years ago. She complained of aggravated dyspnea and chronic cough, and presented fine inspiratory crackles at both lung fields. diffuse ground glass opacity with some area of consolidation and smooth interlobular septal thickenings in both upper, right middle lobes, and a portion of right lower lobe. Optical microscopy of the lung tissue obtained by an open lung biopsy many granulomas containing acid-fast smear positive bacilli and diffuse homogeneous PAS-positive fluid in the alveolar space. Immunohistochemical stain showed surfactant A in the alveolar space. Antituberculosis drugs with bronchoalveolar lavage were used to treat the disease. There after she showed improvement in her symptoms and a partial improvement in the chest X-ray and HRCT findings. We present a case of PAT associated with pulmonary tuberculosis.


Subject(s)
Female , Humans , Middle Aged , Biopsy , Bronchioles , Bronchoalveolar Lavage , Cough , Dyspnea , Glass , Granuloma , Lung , Microscopy , Phospholipids , Alveolar Epithelial Cells , Pulmonary Alveolar Proteinosis , Respiratory Sounds , Thorax , Tuberculosis, Pulmonary
5.
Tuberculosis and Respiratory Diseases ; : 411-418, 2002.
Article in Korean | WPRIM | ID: wpr-137758

ABSTRACT

Pulmonary alveolar proteinosis(PAP) is a disorder in which an insoluble, proteinaceous material, rich in phospholipids, is deposited in the alveoli and bronchioles. The deficiency in the clearance and degradation of the i ntra-alveolar phospholipoproteinaceous material in PAP most likely represents a dysfunction of the type II pneumocytes. Although the pathogenesis and causative treatment of PAP is unclear a whole lung bronchopulmonary lavage is a relatively safe and effective treatment. Here we experienced a case of pulmonary alveolar proteinosis in a 62 year old female patient who had pulmonary tuberculosis approximately 20 years ago. She complained of aggravated dyspnea and chronic cough, and presented fine inspiratory crackles at both lung fields. diffuse ground glass opacity with some area of consolidation and smooth interlobular septal thickenings in both upper, right middle lobes, and a portion of right lower lobe. Optical microscopy of the lung tissue obtained by an open lung biopsy many granulomas containing acid-fast smear positive bacilli and diffuse homogeneous PAS-positive fluid in the alveolar space. Immunohistochemical stain showed surfactant A in the alveolar space. Antituberculosis drugs with bronchoalveolar lavage were used to treat the disease. There after she showed improvement in her symptoms and a partial improvement in the chest X-ray and HRCT findings. We present a case of PAT associated with pulmonary tuberculosis.


Subject(s)
Female , Humans , Middle Aged , Biopsy , Bronchioles , Bronchoalveolar Lavage , Cough , Dyspnea , Glass , Granuloma , Lung , Microscopy , Phospholipids , Alveolar Epithelial Cells , Pulmonary Alveolar Proteinosis , Respiratory Sounds , Thorax , Tuberculosis, Pulmonary
SELECTION OF CITATIONS
SEARCH DETAIL